Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Avoro Capital Advisors LLC
Form 13F · Q2 2026

Avoro Capital Advisors LLC

CIK 1633313Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$11.1B
Reported book value
26
Positions
12
Quarters on record
Top 50
Positions

Avoro Capital Advisors LLC — holdings

Top 26 positions of 26, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1UTHR United Therapeutics Corp Del2.8M+5.6%$1.5B13.5%
2ASND Ascendis Pharma A/S5.1M—$1.4B12.2%
3KRYS Krystal Biotech Inc2.9M+0.0%$1.1B9.6%
4MDGL Madrigal Pharmaceuticals Inc1.8M+0.8%$984M8.8%
5ARGX Argenx Se1.0M+0.0%$928M8.3%
6ARWR Arrowhead Pharmaceuticals In11.4M+6.1%$926M8.3%
7KYMR Kymera Therapeutics Inc7.5M+0.0%$857M7.7%
8RVMD Revolution Medicines Inc2.3M−2.0%$430M3.9%
9CYTK Cytokinetics Inc5.0M+50.0%$426M3.8%
10CELC Celcuity Inc3.4M+0.7%$356M3.2%
11GPCR Structure Therapeutics Inc6.6M+0.0%$352M3.2%
12XENE Xenon Pharmaceuticals Inc5.8M+0.0%$349M3.1%
13DFTX Definium Therapeutics Inc7.2M+43.8%$338M3.0%
14UNIQURE NV Uniqure Nv6.7M+12.9%$310M2.8%
15VERA Vera Therapeutics Inc5.7M−2.8%$246M2.2%
16TSHA Taysha Gene Therapies Inc23.9M+10.1%$163M1.5%
17OCUL Ocular Therapeutix Inc12.5M+1.8%$123M1.1%
18DMRA Damora Therapeutics Inc3.8M+0.0%$98M0.9%
19COAG Hemab Therapeutics Hldgs Inc1.9M—$71M0.6%
20GHRS Gh Research Plc1.8M+0.0%$48M0.4%
21VRDN Viridian Therapeutics Inc2.5M+66.7%$46M0.4%
22SEPN Septerna Inc1.3M+0.0%$45M0.4%
23AVTX Avalo Therapeutics Inc2.3M+65.5%$43M0.4%
24FTH Faeth Therapeutics Inc1.4M—$36M0.3%
25WHWK Whitehawk Therapeutics Inc2.8M+0.0%$13M0.1%
26LXEO Lexeo Therapeutics Inc1.5M−20.6%$7M0.1%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.